William S. Redfern

1.4k total citations
35 papers, 1.1k citations indexed

About

William S. Redfern is a scholar working on Small Animals, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, William S. Redfern has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Small Animals, 13 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in William S. Redfern's work include Animal testing and alternatives (12 papers), Receptor Mechanisms and Signaling (9 papers) and Neuroscience and Neuropharmacology Research (6 papers). William S. Redfern is often cited by papers focused on Animal testing and alternatives (12 papers), Receptor Mechanisms and Signaling (9 papers) and Neuroscience and Neuropharmacology Research (6 papers). William S. Redfern collaborates with scholars based in United Kingdom, United States and Belgium. William S. Redfern's co-authors include Jean‐Pierre Valentin, Matthew J. Winter, Thomas H. Hutchinson, Stewart F. Owen, Alison C. MacKinnon, Christine M. Brown, Tanya T. Whitfield, Keith N. Frayn, Timothy G. Hammond and Brian Woodward and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and Drug Discovery Today.

In The Last Decade

William S. Redfern

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William S. Redfern United Kingdom 19 399 344 215 144 142 35 1.1k
Donald A. Bruun United States 27 756 1.9× 441 1.3× 141 0.7× 28 0.2× 32 0.2× 61 2.1k
Masami Ishido Japan 22 714 1.8× 299 0.9× 38 0.2× 188 1.3× 60 0.4× 75 1.9k
Peter Pörzgen United States 16 375 0.9× 420 1.2× 42 0.2× 34 0.2× 18 0.1× 23 1.1k
J. Alberto Olivares‐Reyes Mexico 21 759 1.9× 280 0.8× 177 0.8× 272 1.9× 6 0.0× 45 1.5k
Peter A. Castro United States 8 284 0.7× 446 1.3× 406 1.9× 32 0.2× 10 0.1× 8 809
Jack W. Miller United States 20 1.2k 3.1× 828 2.4× 94 0.4× 149 1.0× 26 0.2× 46 2.1k
Kimberly P. Keil United States 24 453 1.1× 120 0.3× 49 0.2× 11 0.1× 37 0.3× 57 1.3k
Shripad B. Deshpande India 19 532 1.3× 325 0.9× 27 0.1× 98 0.7× 48 0.3× 101 1.3k
Piera Rebuffat Italy 24 682 1.7× 541 1.6× 48 0.2× 183 1.3× 19 0.1× 141 2.0k
Mikhail Y. Kochukov United States 18 299 0.7× 139 0.4× 29 0.1× 55 0.4× 31 0.2× 22 1.0k

Countries citing papers authored by William S. Redfern

Since Specialization
Citations

This map shows the geographic impact of William S. Redfern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Redfern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Redfern more than expected).

Fields of papers citing papers by William S. Redfern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S. Redfern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Redfern. The network helps show where William S. Redfern may publish in the future.

Co-authorship network of co-authors of William S. Redfern

This figure shows the co-authorship network connecting the top 25 collaborators of William S. Redfern. A scholar is included among the top collaborators of William S. Redfern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Redfern. William S. Redfern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sillito, Rowland R., Claire Grant, Natasha A. Karp, et al.. (2018). Pharmacological validation of individual animal locomotion, temperature and behavioural analysis in group-housed rats using a novel automated home cage analysis system: A comparison with the modified Irwin test. Journal of Pharmacological and Toxicological Methods. 94(Pt 1). 1–13. 13 indexed citations
2.
Pugsley, Michael K., Simon Authier, John Koerner, et al.. (2018). An overview of the safety pharmacology society strategic plan. Journal of Pharmacological and Toxicological Methods. 93. 35–45. 4 indexed citations
3.
Redfern, William S., Claire Grant, David J. Simpson, et al.. (2017). Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project. PLoS ONE. 12(9). e0181068–e0181068. 64 indexed citations
4.
Authier, Simon, Michael K. Pugsley, John Koerner, et al.. (2017). Proarrhythmia liability assessment and the comprehensive in vitro Proarrhythmia Assay (CiPA): An industry survey on current practice. Journal of Pharmacological and Toxicological Methods. 86. 34–43. 26 indexed citations
5.
Authier, Simon, Joseph C. Arezzo, Marcus S. Delatte, et al.. (2016). Safety pharmacology investigations on the nervous system: An industry survey. Journal of Pharmacological and Toxicological Methods. 81. 37–46. 61 indexed citations
6.
Winter, Matthew J., et al.. (2011). Ototoxin-induced cellular damage in neuromasts disrupts lateral line function in larval zebrafish. Hearing Research. 284(1-2). 67–81. 67 indexed citations
7.
Redfern, William S. & Jean‐Pierre Valentin. (2011). Trends in safety pharmacology: Posters presented at the annual meetings of the Safety Pharmacology Society 2001–2010. Journal of Pharmacological and Toxicological Methods. 64(1). 102–110. 23 indexed citations
8.
9.
Easter, Alison, James Damewood, William S. Redfern, et al.. (2009). Approaches to seizure risk assessment in preclinical drug discovery. Drug Discovery Today. 14(17-18). 876–884. 72 indexed citations
10.
Winter, Matthew J., et al.. (2009). 22-P006 The zebrafish as an in vivo model of drug-induced hearing and vestibular impairment. Mechanisms of Development. 126. S330–S330. 1 indexed citations
11.
Redfern, William S., Gareth Waldron, Matthew J. Winter, et al.. (2008). Zebrafish assays as early safety pharmacology screens: Paradigm shift or red herring?. Journal of Pharmacological and Toxicological Methods. 58(2). 110–117. 52 indexed citations
12.
Redfern, William S., et al.. (2008). Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. Journal of Pharmacological and Toxicological Methods. 57(3). 176–187. 151 indexed citations
13.
Bigley, Alison, et al.. (2008). Validation of an OptoMotry system for measurement of visual acuity in Han Wistar rats. Journal of Pharmacological and Toxicological Methods. 58(2). 152–152. 5 indexed citations
14.
Redfern, William S., et al.. (2005). Spectrum of effects detected in the rat functional observational battery following oral administration of non-CNS targeted compounds. Journal of Pharmacological and Toxicological Methods. 52(1). 77–82. 42 indexed citations
15.
Wakefield, Ian, Chris Pollard, William S. Redfern, Timothy G. Hammond, & Jean‐Pierre Valentin. (2002). The application of in vitro methods to safety pharmacology. Fundamental and Clinical Pharmacology. 16(3). 209–218. 33 indexed citations
16.
Redfern, William S., Ian Wakefield, Helen Prior, et al.. (2002). Safety pharmacology – a progressive approach. Fundamental and Clinical Pharmacology. 16(3). 161–173. 48 indexed citations
17.
MacKinnon, Alison C., William S. Redfern, & Christine M. Brown. (1995). [3H]‐RS‐45041‐190: a selective high‐affinity radioligand for I2 imidazoline receptors. British Journal of Pharmacology. 116(2). 1729–1736. 23 indexed citations
18.
Redfern, William S., et al.. (1995). The role of α2‐adrenoceptors in the vasculature of the rat tail. British Journal of Pharmacology. 114(8). 1724–1730. 26 indexed citations
19.
Redfern, William S., et al.. (1993). Modulation of central noradrenergic function by RS‐15385‐197. British Journal of Pharmacology. 108(2). 526–533. 17 indexed citations
20.
Small, Catherine B., Christine M. Brown, William S. Redfern, & Michael Spedding. (1991). The guinea‐pig ileum preparation as a model for 5‐HT1A receptors: anomalous effects with RS‐30199–193. British Journal of Pharmacology. 104(2). 519–525. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald A. Bruun Breakdown of academic impact, for papers by Masami Ishido Breakdown of academic impact, for papers by Peter Pörzgen Breakdown of academic impact, for papers by J. Alberto Olivares‐Reyes Breakdown of academic impact, for papers by Peter A. Castro Breakdown of academic impact, for papers by Jack W. Miller Breakdown of academic impact, for papers by Kimberly P. Keil Breakdown of academic impact, for papers by Shripad B. Deshpande Breakdown of academic impact, for papers by Piera Rebuffat Breakdown of academic impact, for papers by Mikhail Y. Kochukov
Rankless by CCL
2026